company background image
423 logo

Dong-E-E-JiaoLtd SZSE:000423 Stock Report

Last Price

CN¥69.19

Market Cap

CN¥43.6b

7D

5.7%

1Y

36.7%

Updated

18 Apr, 2024

Data

Company Financials +

Dong-E-E-Jiao Co.,Ltd.

SZSE:000423 Stock Report

Market Cap: CN¥43.6b

423 Stock Overview

Dong-E-E-Jiao Co.,Ltd. produces and sells Chinese medicine, health care products, and biological drugs in China.

423 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Dong-E-E-Jiao Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dong-E-E-JiaoLtd
Historical stock prices
Current Share PriceCN¥69.19
52 Week HighCN¥68.55
52 Week LowCN¥44.52
Beta0.67
1 Month Change12.83%
3 Month Change36.42%
1 Year Change36.74%
3 Year Change98.37%
5 Year Change38.27%
Change since IPO4,223.80%

Recent News & Updates

Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest

Mar 31
Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest

Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results

Mar 25
Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results

Recent updates

Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest

Mar 31
Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest

Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results

Mar 25
Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results

Some Shareholders Feeling Restless Over Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) P/E Ratio

Mar 21
Some Shareholders Feeling Restless Over Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) P/E Ratio

Shareholder Returns

423CN PharmaceuticalsCN Market
7D5.7%-0.7%-0.2%
1Y36.7%-15.9%-17.8%

Return vs Industry: 000423 exceeded the CN Pharmaceuticals industry which returned -15.9% over the past year.

Return vs Market: 000423 exceeded the CN Market which returned -17.8% over the past year.

Price Volatility

Is 423's price volatile compared to industry and market?
423 volatility
423 Average Weekly Movement4.8%
Pharmaceuticals Industry Average Movement7.9%
Market Average Movement8.9%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.4%

Stable Share Price: 000423's share price has been volatile over the past 3 months.

Volatility Over Time: 000423's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19523,678Jie Chengwww.dongeejiao.com

Dong-E-E-Jiao Co.,Ltd. produces and sells Chinese medicine, health care products, and biological drugs in China. It offers compound donkey-hide gelatin paste, Enwei compound Ejiao pulp, donkey-hide gelatin jujube, Ejiao Buxue granules, and collagen powders.

Dong-E-E-Jiao Co.,Ltd. Fundamentals Summary

How do Dong-E-E-JiaoLtd's earnings and revenue compare to its market cap?
423 fundamental statistics
Market capCN¥43.55b
Earnings (TTM)CN¥1.15b
Revenue (TTM)CN¥4.72b

38.7x

P/E Ratio

9.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
423 income statement (TTM)
RevenueCN¥4.72b
Cost of RevenueCN¥1.40b
Gross ProfitCN¥3.32b
Other ExpensesCN¥2.17b
EarningsCN¥1.15b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)1.79
Gross Margin70.37%
Net Profit Margin24.41%
Debt/Equity Ratio0%

How did 423 perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

99%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.